Insulin degludec and liraglutide Subcutaneous and Paclitaxel Intravenous
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Paclitaxel Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Paclitaxel Novaplus
- Insulin degludec and liraglutide Subcutaneous-Paclitaxel protein-bound
- Insulin degludec and liraglutide Subcutaneous-Paclitaxel protein-bound Intravenous
- Insulin degludec and liraglutide Subcutaneous-Pacnex
- Insulin degludec and liraglutide Subcutaneous-Pacnex LP
- Insulin degludec and liraglutide Subcutaneous-Pacnex MX
- Paclitaxel Intravenous-Insulin degludec Subcutaneous
- Paclitaxel Intravenous-Insulin detemir
- Paclitaxel Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Paclitaxel Intravenous-Insulin Detemir (Vials)
- Paclitaxel Intravenous-Insulin detemir Subcutaneous
- Paclitaxel Intravenous-Insulin glargine